Your browser doesn't support javascript.
loading
LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.
Dowlati, Afshin; Harvey, R Donald; Carvajal, Richard D; Hamid, Omid; Klempner, Samuel J; Kauh, John Sae Wook; Peterson, Daniel A; Yu, Danni; Chapman, Sonya C; Szpurka, Anna M; Carlsen, Michelle; Quinlan, Tonya; Wesolowski, Robert.
Afiliação
  • Dowlati A; Department of Medicine Division of Hematology and Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH, USA.
  • Harvey RD; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Carvajal RD; Department of Medicine, Division of Hematology/Oncology, Columbia University, College of Physicians and Surgeons New York, New York, NY, USA.
  • Hamid O; Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Cedars-Sinai Affiliate, Los Angeles, CA, USA.
  • Klempner SJ; Department of Medicine and Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Kauh JSW; Medical Oncology, Hutchison MediPharma Inc., Florham Park, NJ, USA.
  • Peterson DA; Eli Lilly and Company, Indianapolis, IN, USA.
  • Yu D; Eli Lilly and Company, Indianapolis, IN, USA.
  • Chapman SC; Eli Lilly and Company, Windlesham, Surrey, UK.
  • Szpurka AM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Carlsen M; Eli Lilly and Company, Indianapolis, IN, USA.
  • Quinlan T; Eli Lilly and Company, Indianapolis, IN, USA.
  • Wesolowski R; Internal Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, 1310D Lincoln Tower, 1800 Cannon Drive, Columbus, OH, 43210, USA. Robert.Wesolowski@osumc.edu.
Invest New Drugs ; 39(4): 1057-1071, 2021 08.
Article em En | MEDLINE | ID: mdl-33624233
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Piridinas / Anticorpos Monoclonais / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Piridinas / Anticorpos Monoclonais / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2021 Tipo de documento: Article